Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Serum Albumin × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Intestinal Neuroendocrine Tumor 1

Interventions

lutetium Lu 177 dotatate 2 Lutetium-177 2 Liquid Biopsy 2 Endoscopic Mucosal Resection 2 Data Collection 2 pentetreotide 1 fluorodopa F 18 1 copper dotatate CU-64 1 Yttrium-90 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Single Photon Emission Computed Tomography Computed Tomography 1 Serum Albumin 1 Resveratrol 1 Respiratory Therapy 1 Referral and Consultation 1 Radiofrequency Ablation 1 Quality of Life 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Octreotide 1 Nutrition Assessment 1 Needles 1 Magnetic Resonance Spectroscopy 1 Drug Therapy 1 Diet Therapy 1 Cryosurgery 1 Control Groups 1 Betaine 1 90Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡